Namely, in Leucin-Rich Repeat Kinase 2 (LRRK2) gene mutated PD, increased serotonin transporter binding in the striatum, brainstem, and hypothalamus during the prodromal phase has been observed and was suggested as a compensatory mechanism (Wile et al. 2017). This evidence concerns the gene LRRK2 and Parkinson disease.